FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

8156511000001102: Zomig Rapimelt 5mg tablets (AstraZeneca) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
20903501000001119 Zomig Rapimelt 5mg tablets (AstraZeneca) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
112400401000001112 Zomig Rapimelt 5mg orodispersible tablets (Grunenthal Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zomig Rapimelt 5mg tablets (AstraZeneca) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) Is a Zolmitriptan 5mg orodispersible tablets true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) Has excipient Aspartame false Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) Has active ingredient Zolmitriptan true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) Has manufactured dose form Conventional release oral lyophilisate false Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) Is a Zomig Rapimelt true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) Has specific active ingredient Zolmitriptan true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) Has dispensed dose form Orodispersible tablet false Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) Has manufactured dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet Is pack of False Zomig Rapimelt 5mg tablets (AstraZeneca) Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet Has AMP True Zomig Rapimelt 5mg tablets (AstraZeneca) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start